1-20 of 21
Annette S. Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

We Have More in Common Than What Sets Us Apart: Shared Founding Drivers in Myeloid Neoplasms and T-cell Lymphomas

Mark G. Evans, MD, Annette S. Kim, MD, PhD
Journal: The Hematologist
The Hematologist (2020) 18 (1)
Published: 2020
Articles

Not a oNe TRacK Solid Tumor Mindset Anymore: NTRK Mutations in Hematologic Malignancies

Damodaran Narayanan, MBBS, PhD, Annette S. Kim, MD, PhD
Journal: The Hematologist
The Hematologist (2020) 17 (6)
Published: 2020
Articles

Long-Term Effects of Donor-derived Clonal Hematopoiesis: The Gift That Keeps on Giving?

Annette S. Kim, MD, PhD
Journal: The Hematologist
The Hematologist (2020) 17 (5)
Published: 2020
Articles

Unmasking the Immunopathological Characteristics of COVID-19: Monocytes Grow With the Flow and Lymphocytes Shelter in Place?

Daniel DiToro, MD, PhD, Annette S. Kim, MD, PhD
Journal: The Hematologist
The Hematologist (2020) 17 (4)
https://doi.org/10.1182/hem.V17.4.12884901943
Published: 2020
Articles

Spots and Dots

Olga Pozdnyakova, MD, PhD, Annette S. Kim, MD, PhD
Journal: The Hematologist
The Hematologist (2020) 17 (4)
https://doi.org/10.1182/hem.V17.4.10411
Published: 2020
Articles

Using Artificial Intelligence to Enhance Diagnosis: Is Resistance Futile?

Annette S. Kim, MD, PhD, Ian Brain, MD
Journal: The Hematologist
The Hematologist (2020) 17 (3)
https://doi.org/10.1182/hem.V17.3.10379
Published: 2020
Articles

How FLT3-ITDs and NPM1 Insertions Maneuver Into AML Using the Lymphoid Enzyme TdT to Initiate Replication Slippage

Annette S. Kim, MD, PhD, John C. LaMacchia, MD, PhD
Journal: The Hematologist
The Hematologist (2020) 17 (2)
https://doi.org/10.1182/hem.V17.2.10277
Published: 2020
Articles

Are You a Lumper or a Splitter? Embrace the Genomic Spectrum of Neutrophilic Myeloid Neoplasms

Annette S. Kim, MD, PhD, Christopher B. Hergott, MD, PhD
Journal: The Hematologist
The Hematologist (2019) 17 (1)
https://doi.org/10.1182/hem.V17.1.10150
Published: 2019
Articles

Primed for Self-Destruction: Adding Venetoclax to Azacitidine for MDS

Annette S. Kim, MD, PhD, Jacqueline S. Garcia, MD, Anthony Letai, MD, PhD
Journal: The Hematologist
The Hematologist (2019) 16 (6)
Published: 2019
Articles

Primed for Self-Destruction: Adding Venetoclax to Azacitidine for MDS

Annette S. Kim, MD, PhD, Jacqueline S. Garcia, MD, Anthony Letai, MD, PhD
Journal: The Hematologist
The Hematologist (2019) 16 (6)
https://doi.org/10.1182/hem.V16.6.9942
Published: 2019
Articles

Escape Mechanisms in Allosteric IDH Inhibition

Annette S. Kim, MD, PhD
Journal: The Hematologist
The Hematologist (2019) 16 (5)
https://doi.org/10.1182/hem.V16.5.9804
Published: 2019
Articles

Seeking Insight Into the AML Subpopulations and Microenvironment Through Single-cell RNA-Seq

Annette S. Kim, MD, PhD
Journal: The Hematologist
The Hematologist (2019) 16 (4)
https://doi.org/10.1182/hem.V16.4.9644
Published: 2019
Articles

Leukemia Is Exhausting...

Annette S. Kim, MD, PhD
Journal: The Hematologist
The Hematologist (2019) 16 (3)
https://doi.org/10.1182/hem.V16.3.9554
Published: 2019
Articles

Monitoring Treatment Response in Multiple Myeloma: Wading Into the Deep End

Madhu M. Ouseph, MD, PhD, Annette S. Kim, MD, PhD
Journal: The Hematologist
The Hematologist (2019) 16 (2)
https://doi.org/10.1182/hem.V16.2.9457
Published: 2019
Articles

Molecular Versus Morphologic Classifications of Myeloproliferative Neoplasms: You Don't Know JAK!

Vignesh Shanmugam, MD, Annette S. Kim, MD, PhD
Journal: The Hematologist
The Hematologist (2018) 16 (1)
https://doi.org/10.1182/hem.V16.1.9295
Published: 2018
Articles

Bring Novel Agents to the Fore in B-ALL: Adding Inotuzumab to Pediatric-Inspired Regimens for AYAs

Marlise R. Luskin, MD, MSCE, Annette S. Kim, MD, PhD, Daniel J. DeAngelo, MD, PhD
Journal: The Hematologist
The Hematologist (2018) 15 (6)
https://doi.org/10.1182/hem.V15.6.9041
Published: 2018
Articles

Circulating Tumor DNA in Lymphoma Monitoring: Fantasy, Fad, or Fact?

Annette S. Kim, MD, PhD
Journal: The Hematologist
The Hematologist (2018) 15 (5)
https://doi.org/10.1182/hem.V15.5.8943
Published: 2018
Articles

The Usual Suspects Aren't Always the Bad Guys! Molecular MRD Comes of Age in AML

Annette S. Kim, MD, PhD
Journal: The Hematologist
The Hematologist (2018) 15 (4)
https://doi.org/10.1182/hem.V15.4.8685
Published: 2018
Articles

BETting on Targeted Therapy for ASXL1-mutated Myeloid Neoplasms

Annette S. Kim, MD, PhD
Journal: The Hematologist
The Hematologist (2018) 15 (3)
https://doi.org/10.1182/hem.V15.3.8462
Published: 2018
Articles

A Real Nose-Pincher

Yi Li, MD, MSc, Annette S. Kim, MD, PhD
Journal: The Hematologist
The Hematologist (2018) 15 (3)
https://doi.org/10.1182/hem.V15.3.8512
Published: 2018